M&A Deal Summary

Numinus Wellness Acquires MedBright AI

On June 20, 2024, Numinus Wellness acquired information technology company MedBright AI

Acquisition Highlights
  • This is Numinus Wellness’ 1st transaction in the Information Technology sector.
  • This is Numinus Wellness’ 3rd transaction in Canada.
  • This is Numinus Wellness’ 1st transaction in British Columbia.

M&A Deal Summary

Date 2024-06-20
Target MedBright AI
Sector Information Technology
Buyer(s) Numinus Wellness
Deal Type Add-on Acquisition

Target

MedBright AI

Vancouver, British Columbia, Canada
MedBright AI deploys artificial intelligence and machine learning (“AI”) to empower medical professionals to deliver increased access to healthcare, reduce healthcare costs, and improve patient outcomes. MedBright AI is based in Vancouver, British Columbia.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Numinus Wellness

Vancouver, British Columbia, Canada

Category Company
Founded 1964
Sector Healthcare Services
Revenue 23M CAD (2023)
DESCRIPTION

Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. Numinus Wellness was founded in 1964 and is based in Vancouver, Canada.


DEAL STATS #
Overall 3 of 3
Sector (Information Technology) 1 of 1
Type (Add-on Acquisition) 3 of 3
State (British Columbia) 1 of 1
Country (Canada) 3 of 3
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-12 Novamind

Toronto, Ontario, Canada

Novamind is a mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. The company provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specializing in clinical trials and evidence-based research for psychedelic medicine. Novamind is based in Toronto, Ontario.

Buy CA$26M